Cannabinoid Receptor Modulation

Cannabinoid Receptor Modulation is a pharmacological mechanism involving the alteration of cannabinoid receptor activity—primarily CB1 and CB2 receptors—through endogenous, exogenous, or synthetic ligands, thereby influencing downstream signaling pathways implicated in anxiety regulation within the context of anxiolytic pharmacology.

3.3K

Publications

259.2K

Citations

12K

Authors

2.1K

Institutions

Publications per year

2017–2026

687

Authors

12K

  1. KM
    Ken Mackie

    Indiana University Bloomington, United States

    83 publications · 13.3K citations

    50

    h-index

  2. VD
    Vincenzo Di Marzo

    National Research Council, Italy

    72 publications · 10.4K citations

    50

    h-index

  3. BL
    Beat Lutz

    Johannes Gutenberg University Mainz, Germany

    62 publications · 9.9K citations

    44

    h-index

  4. GM
    Giovanni Marsicano

    Neurocentre Magendie, France

    50 publications · 8.9K citations

    42

    h-index

  5. BR
    Billy R. Martin

    Virginia Commonwealth University Medical Center, United States

    51 publications · 6.1K citations

    38

    h-index

1–5 of 12K

Venues

  1. British Journal of Pharmacology

    BJP · 145 publications · 15.4K citations

    71

    h-index

  2. European Journal of Pharmacology

    EJP · 134 publications · 9.1K citations

    62

    h-index

  3. Neuropharmacology

    143 publications · 7.9K citations

    51

    h-index

  4. Journal of Neuroscience

    62 publications · 9.9K citations

    51

    h-index

  5. 50

    h-index

1–5